| Literature DB >> 35113021 |
Tania Gardner1,2, Regina Schultz3, Hila Haskelberg1, Jill M Newby4, Jane Wheatley2, Michael Millard1, Steven G Faux2,4, Christine T Shiner1,2,4.
Abstract
BACKGROUND: Internet-based treatment programs present a solution for providing access to pain management for those unable to access clinic-based multidisciplinary pain programs. Attrition from internet interventions is a common issue. Clinician-supported guidance can be an important feature in web-based interventions; however, the optimal level of therapist guidance and expertise required to improve adherence remains unclear.Entities:
Keywords: adherence; chronic pain; clinician guidance; digital health; eHealth; internet interventions; multidisciplinary; online pain management; telephone support
Mesh:
Year: 2022 PMID: 35113021 PMCID: PMC8855305 DOI: 10.2196/30880
Source DB: PubMed Journal: J Med Internet Res ISSN: 1438-8871 Impact factor: 5.428
Reboot Online lesson content.
| Lesson title | Lesson content | Homework activities | Lesson resources (PDF or video) |
| Lesson 1: What Is Chronic Pain and What Is the Best Way to Manage It? |
Chronic pain explained The Brick Wall of Chronic Pain Medication overview The movement station |
Review of acute vs chronic pain Complete own Brick Wall of Chronic Pain Instructions for the movement station |
Welcome (video) Medication management (video) |
| Lesson 2: Goal-Setting and Moving Toward Acceptance |
Scans, test results, and pain The cycle of chronic pain Moving toward acceptance SMARTa goals |
Reviewing the cycle of pain Identifying acceptance, change, and goals Setting short- and long-term SMART goals |
Medical imaging (video) Making life changes (PDF) |
| Lesson 3: Movement, Pacing, and Daily Activity Scheduling |
Exploring the relationship between pain and activity Learning about the “Boom Bust” pattern Fear avoidance beliefs Importance of pacing Introduction to daily activity scheduling |
Identifying healthy vs unhealthy coping skills Pacing activity Keeping a movement diary |
Daily activity scheduling (PDF) |
| Lesson 4: Monitoring Thoughts and Recognizing Unhelpful Thinking Patterns |
Revision of chronic pain cycle and the link among thoughts, feelings, and behaviors Recognizing unhelpful thinking patterns Monitoring thoughts and learning to think more helpful thoughts |
Ways to recognize own unhelpful thinking patterns Complete thought record Continue to monitor and track thoughts | —b |
| Lesson 5: Mood and Pain, Thought Challenging, and Managing Arousal |
Challenging unhelpful thinking Activity planning in practice Emotions and pain Strategies to manage anxiety Mood |
Thought-challenging situations Activity planning and monitoring Managing anger: looking out for triggers and learning strategies Practicing relaxation |
My Thought Challenging Worksheet (PDF) |
| Lesson 6: Stress Management and Getting Better Sleep |
What is stress? How to manage stress better Using problem solving Barriers to good sleep with chronic pain and ways to get better sleep |
Recognizing sources of stress and own signs and symptoms Structured problem-solving task Sleep diary to improve habits |
Good sleep guide (PDF) Better sleep for chronic pain (video) |
| Lesson 7: Communication and Relationships |
What is good communication? Communication styles Relationships with others Ways to improve those relationships |
Communication skills practice Task: select a relationship and explore how you would like that relationship to be different Revisiting thought-challenging exercise |
Conversation skills tips (PDF) Chronic pain and information for family and friends (PDF) |
| Lesson 8: Managing Flare-ups and Continuing Management of Chronic Pain |
Exploring flare-ups, relapse, and the need for a flare-up plan Continuing chronic pain management How to get further help |
Ten things to help during a relapse Flare-up prevention plan Summary |
What is a pain clinic? (video) Congratulations (video) |
aSMART: specific, measurable, achievable, relevant, and timely.
bNot available.
Baseline demographics (N=89).
| Characteristics | Total sample (N=89) | Intervention (n=44) | Control (n=45) | Between-group comparison | |||||||||
|
|
|
|
| Values | |||||||||
| Age (years), mean (SD) | 49.3 (16.1) | 48.0 (15.8) | 50.6 (16.4) | t84=–0.74 | .46 | ||||||||
|
| .34 | ||||||||||||
|
| Male | 28 (32) | 13 (30) | 15 (33) |
|
| |||||||
|
| Female | 59 (66) | 29 (66) | 30 (67) |
|
| |||||||
|
| Nonbinary | 2 (2) | 2 (5) | 0 (0) |
|
| |||||||
|
| .17 | ||||||||||||
|
| Major city | 52 (58) | 29 (66) | 23 (51) |
|
| |||||||
|
| Regional or remote | 37 (42) | 15 (34) | 22 (49) |
|
| |||||||
| Major depressive disorder, n (%) | 28 (32) | 16 (36) | 12 (27) | .33 | |||||||||
| Opioid analgesia, n (%) | 39 (44) | 14 (33) | 25 (56) |
| |||||||||
| Antidepressants, n (%) | 38 (43) | 20 (47) | 18 (40) | .54 | |||||||||
| Anticonvulsants, n (%) | 24 (27) | 13 (30) | 11 (24) | .54 | |||||||||
| Benzodiazepines, n (%) | 16 (18) | 8 (19) | 8 (18) | .92 | |||||||||
| Simple analgesia, n (%) | 44 (49) | 18(41) | 26 (58) | .11 | |||||||||
aItalicized results are significant at P<.05.
Figure 1Participant flowchart.
Estimated marginal means (EMMs) before and after treatment and at follow-up and within- and between-group effect sizes.
| Outcome | Before treatment, EMM (SD) | After treatment, EMM (SD) | Follow-up, EMM (SD) | Pre- to posttreatment within-group comparison | Posttreatment to follow-up within-group comparison | Posttreatment between-group comparison, between-group effect size, Hedges g (95% CI) | Follow-up, between-group comparison, between-group effect size, Hedges g (95% CI) | |||||||||||||||
|
|
|
|
|
| Within-group effect size, Hedges g (95% CI) |
| Within-group effect size, Hedges g (95% CI) |
|
| |||||||||||||
|
| ||||||||||||||||||||||
|
| Intervention | 26.9 (10.9) | 33.9 (12.0) | 33.8 (12.3) | 0.73 | 0.61 (0.08 to 1.14)b | 0.92 | 0.01 (–0.57 to 0.59) | 0.43 (–0.12 to –0.99) | 0.32 (–0.26 to –0.89) | ||||||||||||
|
| Control | 28.7 (10.0) | 38.9 (10.5) | 37.7 (11.9) | 0.37 | 0.98 (0.28 to 1.67)b | 0.62 | 0.10 (–0.55 to 0.76) | N/Ac | N/A | ||||||||||||
|
| ||||||||||||||||||||||
|
| Intervention | 37.4 (6.2) | 33.1 (8.0) | 33.2 (7.1) | 0.60 | 0.60 (0.07 to 1.12)b | 0.74 | 0.01 (–0.57 to 0.58) | 0.50 (–0.05 to –1.04) | 0.23 (–0.33 to –0.80) | ||||||||||||
|
| Control | 40.6 (5.9) | 36.9 (7.2) | 34.8 (7.1) | 0.38 | 0.54 (–0.11 to –1.19)e | 0.72 | 0.29 (–0.35 to 0.93) | N/A | N/A | ||||||||||||
|
| ||||||||||||||||||||||
|
| Intervention | 5.4 (1.4) | 5.1 (1.5) | 5.3 (1.4) | 0.63 | 0.25 (–0.27 to –0.76) | 0.81 | 0.19 (–0.39 to 0.77) | 0.04 (–0.50 to –0.57) | 0.36 (–0.21 to –0.94) | ||||||||||||
|
| Control | 5.4 (1.3) | 5.0 (1.4) | 4.8 (1.4) | 0.66 | 0.28 (–0.36 to 0.91) | 0.80 | 0.13 (–0.50 to 0.77) | N/A | N/A | ||||||||||||
|
| ||||||||||||||||||||||
|
| Intervention | 6.4 (1.8) | 5.3 (2.1) | 4.9 (2.2) | 0.75 | 0.59 (0.06 to 1.11)b | 0.78 | 0.15 (–0.43 to 0.73) | 0.01 (–0.5 to –0.55) | 0.21 (–0.36 to 0.78) | ||||||||||||
|
| Control | 6.2 (1.7) | 5.2 (1.9) | 4.5 (2.2) | 0.22 | 0.53 (–0.12 to –1.18) | 0.75 | 0.36 (–0.28 to 1.00) | N/A | N/A | ||||||||||||
|
| ||||||||||||||||||||||
|
| Intervention | 40.1 (12.2) | 30.9 (15.6) | 31.0 (16.2) | 0.69 | 0.65 (0.12 to 1.18)b | 0.63 | 0.01 (–0.57 to 0.59) | 0.07 (–0.47 to –0.60) | 0.23 (–0.34 to –0.80) | ||||||||||||
|
| Control | 38.2 (11.5) | 31.9 (13.9) | 27.3 (15.8) | 0.52 | 0.49 (–0.16 to –1.13)e | 0.82 | 0.31 (–0.33 to 0.94) | N/A | N/A | ||||||||||||
|
| ||||||||||||||||||||||
|
| Intervention | 1571.9 (1709.8) | 2783.4 (2790.3) | 2353.7 (2391.5) | 0.68 | 0.53 (0.01 to 1.05)e | 0.56 | 0.17 (–0.41 to 0.75) | 0.18 (–0.37 to –0.74) | 0.24 (–0.33 to –0.81) | ||||||||||||
|
| Control | 2176.6 (1472.6) | 2278.5 (2698.4) | 1766.6 (2525.9) | 0.49 | 0.05 (–0.54 to –0.64) | 0.70 | 0.19 (–0.40 to 0.78) | N/A | N/A | ||||||||||||
|
| ||||||||||||||||||||||
|
| Intervention | 27.3 (6.8) | 23.2 (7.5) | 23.6 (8.7) | 0.76 | 0.57 (0.04 to 1.09)b | 0.71 | 0.05 (–0.53 to 0.63) | 0.07 (–0.49 to –0.63) | 0.02 (–0.54 to –0.59) | ||||||||||||
|
| Control | 26.4 (5.9) | 22.7 (6.3) | 23.4 (8.3) | 0.40 | 0.59 (–0.12 to –1.30)e | 0.71 | 0.09 (–0.58 to 0.77) | N/A | N/A | ||||||||||||
aPSEQ: Pain Self-Efficacy Questionnaire.
bSignificance at P<.001.
cN/A: not applicable.
dTSK: Tampa Scale for Kinesiophobia.
eSignificance at P<.05.
fBPI: Brief Pain Inventory.
gPDI: Pain Disability Index.
hIPAQ: International Physical Activity Questionnaire.
iK10: Kessler-10 Psychological Distress Scale.